BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 5.49
-0.08 (-1.44%)
Nov 9, 2026, 11:34 AM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 47.94 million as of November 9, 2026. It is the 32,657th most valuable company in the world and the 931st biggest in Canada. Its market cap has increased by 60.05% in one year.
Market Cap
47.94M
Enterprise Value
17.94M
Revenue
n/a
Global Rank
Country Rank
#931 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 47.94M, an increase of 96.34%. That is a compound annual growth rate of 5.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 47.94M | 159.67% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helix BioPharma | 68.74M |
| NurExone Biologic | 48.20M |
| Thiogenesis Therapeutics | 44.79M |
| Sharp Therapeutics | 43.26M |
| Sernova Biotherapeutics | 41.54M |
| Medicenna Therapeutics | 40.61M |
| Microbix Biosystems | 39.04M |
| Sona Nanotech | 36.23M |